Activity of Ponatinib and Vitamin K2 Against Myelodysplastic Syndrome and Acute Myeloid Leukemia Cells.

Saved in:
Bibliographic Details
Title: Activity of Ponatinib and Vitamin K2 Against Myelodysplastic Syndrome and Acute Myeloid Leukemia Cells.
Authors: Okabe S; Department of Hematology, Tokyo Medical University, Tokyo, Japan okabe@tokyo-med.ac.jp., Yoshizawa S; Department of Hematology, Tokyo Medical University, Tokyo, Japan., Osone K; Department of Hematology, Tokyo Medical University, Tokyo, Japan., Arai Y; Department of Hematology, Tokyo Medical University, Tokyo, Japan., Moriyama M; Department of Hematology, Tokyo Medical University, Tokyo, Japan., Akahane D; Department of Hematology, Tokyo Medical University, Tokyo, Japan.
Source: Anticancer research [Anticancer Res] 2026 Mar; Vol. 46 (3), pp. 1247-1257.
Publication Type: Journal Article
Journal Info: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1791-7530
DOI:10.21873/anticanres.18026